2024 Q1 Form 10-K Financial Statement

#000162828024005919 Filed on February 21, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $415.0K $295.0K $1.193M
YoY Change 78.11% -0.67% 17.08%
Cost Of Revenue $280.0K $166.0K $654.0K
YoY Change 98.58% -8.29% 17.84%
Gross Profit $135.0K $129.0K $539.0K
YoY Change 46.74% 11.21% 16.16%
Gross Profit Margin 32.53% 43.73% 45.18%
Selling, General & Admin $1.608M $1.784M $7.043M
YoY Change -8.11% -1.22% -14.93%
% of Gross Profit 1191.11% 1382.95% 1306.68%
Research & Development $370.0K $81.00K $1.228M
YoY Change 3.06% -81.38% -33.94%
% of Gross Profit 274.07% 62.79% 227.83%
Depreciation & Amortization $37.00K $31.00K $135.0K
YoY Change 2.78% -11.43% -26.23%
% of Gross Profit 27.41% 24.03% 25.05%
Operating Expenses $1.978M $1.865M $8.271M
YoY Change -7.44% -17.7% -18.42%
Operating Profit -$1.843M -$1.736M -$7.732M
YoY Change -9.88% -19.26% -20.07%
Interest Expense $11.00K $3.000K $22.00K
YoY Change 37.5% 50.0% 340.0%
% of Operating Profit
Other Income/Expense, Net $11.00K $0.00 $22.00K
YoY Change 37.5% -204.76%
Pretax Income -$1.832M -$1.733M -$7.710M
YoY Change -10.06% -19.32% -20.47%
Income Tax
% Of Pretax Income
Net Earnings -$1.832M -$1.733M -$7.710M
YoY Change -10.06% -19.32% -20.47%
Net Earnings / Revenue -441.45% -587.46% -646.27%
Basic Earnings Per Share -$0.36 -$11.51
Diluted Earnings Per Share -$0.36 -$0.90 -$11.51
COMMON SHARES
Basic Shares Outstanding 5.145M shares 3.631M shares 669.9K shares
Diluted Shares Outstanding 5.145M shares 669.9K shares

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.562M $5.395M $5.395M
YoY Change 29.62% 12.98% 12.98%
Cash & Equivalents $3.600M $5.400M
Short-Term Investments
Other Short-Term Assets $346.0K $388.0K $388.0K
YoY Change -23.11% 2.65% 2.65%
Inventory $874.0K $795.0K $795.0K
Prepaid Expenses $346.0K $388.0K
Receivables $161.0K $95.00K $95.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $4.943M $6.673M $6.673M
YoY Change 21.78% 9.05% 9.05%
LONG-TERM ASSETS
Property, Plant & Equipment $353.0K $388.0K $598.0K
YoY Change -37.41% 31.97% -6.71%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $22.00K $22.00K $22.00K
YoY Change 0.0% 0.0% 0.0%
Total Long-Term Assets $529.0K $620.0K $620.0K
YoY Change -9.73% -6.49% -6.49%
TOTAL ASSETS
Total Short-Term Assets $4.943M $6.673M $6.673M
Total Long-Term Assets $529.0K $620.0K $620.0K
Total Assets $5.472M $7.293M $7.293M
YoY Change 17.8% 7.53% 7.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $116.0K $150.0K $150.0K
YoY Change -46.05% -72.22% -72.22%
Accrued Expenses $391.0K $368.0K $585.0K
YoY Change -49.09% -34.29% -20.95%
Deferred Revenue $15.00K $18.00K
YoY Change -59.09%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $34.00K $33.00K $33.00K
YoY Change
Total Short-Term Liabilities $715.0K $786.0K $786.0K
YoY Change -29.63% -40.63% -40.63%
LONG-TERM LIABILITIES
Long-Term Debt $147.0K $156.0K $156.0K
YoY Change
Other Long-Term Liabilities $0.00 $0.00
YoY Change -100.0% -100.0%
Total Long-Term Liabilities $147.0K $156.0K $156.0K
YoY Change 11.36% -12.85% -12.85%
TOTAL LIABILITIES
Total Short-Term Liabilities $715.0K $786.0K $786.0K
Total Long-Term Liabilities $147.0K $156.0K $156.0K
Total Liabilities $862.0K $942.0K $942.0K
YoY Change -24.91% -37.33% -37.33%
SHAREHOLDERS EQUITY
Retained Earnings -$131.7M -$129.9M
YoY Change 6.3%
Common Stock $5.000K $5.000K
YoY Change 400.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.610M $6.351M $6.351M
YoY Change
Total Liabilities & Shareholders Equity $5.472M $7.293M $7.293M
YoY Change 17.8% 7.53% 7.53%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$1.832M -$1.733M -$7.710M
YoY Change -10.06% -19.32% -20.47%
Depreciation, Depletion And Amortization $37.00K $31.00K $135.0K
YoY Change 2.78% -11.43% -26.23%
Cash From Operating Activities -$1.829M -$2.019M -$7.566M
YoY Change -9.23% -8.64% -11.79%
INVESTING ACTIVITIES
Capital Expenditures $2.000K $35.00K $149.0K
YoY Change 100.0% -10.26% -14.37%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities -$2.000K -$35.00K -$149.0K
YoY Change 100.0% 0.0% -12.35%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $5.407M
YoY Change 27.89%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$2.000K 5.304M $8.335M
YoY Change -81.82% 25.45% 98.64%
NET CHANGE
Cash From Operating Activities -$1.829M -2.019M -$7.566M
Cash From Investing Activities -$2.000K -35.00K -$149.0K
Cash From Financing Activities -$2.000K 5.304M $8.335M
Net Change In Cash -$1.833M 3.250M $620.0K
YoY Change -9.57% 63.89% -113.62%
FREE CASH FLOW
Cash From Operating Activities -$1.829M -$2.019M -$7.566M
Capital Expenditures $2.000K $35.00K $149.0K
Free Cash Flow -$1.831M -$2.054M -$7.715M
YoY Change -9.18% -8.67% -11.84%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-37941
CY2023 dei Entity Registrant Name
EntityRegistrantName
SENESTECH, INC.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-2079805
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 110
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Phoenix
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
AZ
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
85027
CY2023 dei City Area Code
CityAreaCode
(928)
CY2023 dei Local Phone Number
LocalPhoneNumber
779-4143
CY2023 dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
CY2023 dei Trading Symbol
TradingSymbol
SNES
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5395000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
95000 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
388000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
795000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
6673000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
210000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
388000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
22000 usd
CY2023Q4 us-gaap Assets
Assets
7293000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
540000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
560000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
180000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
18000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
786000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5140024 shares
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1019000 usd
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
555000 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8279000 usd
CY2022 us-gaap Investment Income Net
InvestmentIncomeNet
7000 usd
CY2022 us-gaap Interest Expense Debt
InterestExpenseDebt
2000 usd
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-2000 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-20000 usd
CY2023 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
4000 usd
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
10000 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-58000 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-390000 usd
CY2023 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-192000 usd
CY2023 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-26000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7566000 usd
CY2023 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
149000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-149000 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5407000 usd
CY2023Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
4200000 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2023 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0 usd
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
99000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
95000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6000 usd
CY2023 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
2000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4000 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
747000 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
99000 usd
CY2022Q4 us-gaap Inventory Gross
InventoryGross
871000 usd
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
18000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
853000 usd
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
29000 usd
CY2022 snes Inventory Valuation Reserves Additions
InventoryValuationReservesAdditions
0 usd
CY2022 snes Inventory Valuation Reserves Amount Relieved
InventoryValuationReservesAmountRelieved
11000 usd
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
18000 usd
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
61000 usd
CY2023Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
14000 usd
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
16000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2419000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
388000 usd
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
135000 usd
CY2023Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
232000 usd
CY2023Q4 snes Legal Services Current
LegalServicesCurrent
121000 usd
CY2023Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
15000 usd
CY2023Q4 snes Personal Property And Franchise Tax
PersonalPropertyAndFranchiseTax
0 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
0 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
368000 usd
CY2022Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
42.00
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001680378
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.05
CY2023 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0833
CY2023Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0833
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
23460 N. 19th Ave
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
3320000 usd
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5144632 shares
CY2023 dei Auditor Firm
AuditorFirmId
2738
CY2023 dei Auditor Name
AuditorName
M&K CPAS, PLLC
CY2023 dei Auditor Location
AuditorLocation
Houston, TX
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4775000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
113000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
378000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
853000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
6119000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
347000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
294000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
22000 usd
CY2022Q4 us-gaap Assets
Assets
6782000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
150000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
368000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
217000 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
33000 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
0 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
44000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1324000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
179000 usd
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
156000 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
0 usd
CY2023Q4 us-gaap Liabilities
Liabilities
942000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1503000 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5140024 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
67472 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
67472 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
5000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
136259000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
127482000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-129913000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-122203000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
6351000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
5279000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7293000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6782000 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1193000 usd
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
654000 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-7732000 usd
CY2023 us-gaap Investment Income Net
InvestmentIncomeNet
26000 usd
CY2023 us-gaap Interest Expense Debt
InterestExpenseDebt
4000 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-26000 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
22000 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-21000 usd
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7710000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-7710000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-9695000 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9695000 usd
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
669861 shares
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
669861 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65473 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65473 shares
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-11.51
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-11.51
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-148.08
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-148.08
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
10035000 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
707000 usd
CY2022 snes Stock Issued During Period Value New Issues And Prefunding Warrants
StockIssuedDuringPeriodValueNewIssuesAndPrefundingWarrants
4228000 usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
4000 usd
CY2022 snes Stock Issued During Period Shares Fractional Shares From Reverse Stock Split
StockIssuedDuringPeriodSharesFractionalSharesFromReverseStockSplit
4 shares
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-9695000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
5279000 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
455000 usd
CY2023 snes Stock Issued During Period Value New Issues And Prefunding Warrants
StockIssuedDuringPeriodValueNewIssuesAndPrefundingWarrants
5407000 usd
CY2023 snes Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
2831000 usd
CY2023 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
100000 usd
CY2023 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-11000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-7710000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
6351000 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-7710000 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-9695000 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
135000 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
183000 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
555000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
711000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
378000 usd
CY2023 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 usd
CY2022 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-28000 usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
6000 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
42000 usd
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
0 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
148000 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-148000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
206000 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-18000 usd
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
44000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8577000 usd
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
4000 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
174000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-170000 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4228000 usd
CY2023 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
2831000 usd
CY2022 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
CY2023 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
114000 usd
CY2022 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
CY2023 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
6000 usd
CY2022 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
5000 usd
CY2023 snes Repayments Of Finance Lease Obligations
RepaymentsOfFinanceLeaseObligations
0 usd
CY2022 snes Repayments Of Finance Lease Obligations
RepaymentsOfFinanceLeaseObligations
27000 usd
CY2023 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
11000 usd
CY2022 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8335000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4196000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
620000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4551000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4775000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9326000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5395000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4775000 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
4000 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
1000 usd
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2023 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
81000 usd
CY2022 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0 usd
CY2023Q4 snes Number Of States Registration Received
NumberOfStatesRegistrationReceived
50 state
CY2023Q4 snes Number Of States Approved Removal Of Restricted Use Designation
NumberOfStatesApprovedRemovalOfRestrictedUseDesignation
49 state
CY2023Q4 snes Number Of Major Us Territories Registration Received
NumberOfMajorUSTerritoriesRegistrationReceived
5 territory
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-129900000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5400000 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of our financial statements and related disclosures in accordance with U.S. GAAP requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue, costs and expenses, and the disclosure of contingent assets and liabilities in our financial statements. We base our estimates on historical experience, known trends and events and various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We evaluate our estimates and assumptions on an ongoing basis. Our actual results may differ from these estimates under different conditions.</span></div>
CY2023Q4 snes Marketing Programs And Conferences
MarketingProgramsAndConferences
1000 usd
CY2022Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
4400000 usd
CY2023 us-gaap Advertising Expense
AdvertisingExpense
238000 usd
CY2022 us-gaap Advertising Expense
AdvertisingExpense
369000 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2022 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0 usd
CY2022Q4 snes Marketing Programs And Conferences
MarketingProgramsAndConferences
74000 usd
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
6000 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
388000 usd
CY2022Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
119000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
113000 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2022 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
8000 usd
CY2023 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
4000 usd
CY2022 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
2000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6000 usd
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
772000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
53000 usd
CY2023Q4 us-gaap Inventory Gross
InventoryGross
800000 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
5000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
795000 usd
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
18000 usd
CY2023 snes Inventory Valuation Reserves Additions
InventoryValuationReservesAdditions
0 usd
CY2023 snes Inventory Valuation Reserves Amount Relieved
InventoryValuationReservesAmountRelieved
13000 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
5000 usd
CY2023Q4 snes Prepaid Software Licenses Current
PrepaidSoftwareLicensesCurrent
152000 usd
CY2022Q4 snes Prepaid Software Licenses Current
PrepaidSoftwareLicensesCurrent
157000 usd
CY2023Q4 snes Prepaid Inventory Current
PrepaidInventoryCurrent
111000 usd
CY2022Q4 snes Prepaid Inventory Current
PrepaidInventoryCurrent
0 usd
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
64000 usd
CY2023Q4 snes Professional Services Retainer
ProfessionalServicesRetainer
30000 usd
CY2022Q4 snes Professional Services Retainer
ProfessionalServicesRetainer
41000 usd
CY2022Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
39000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2283000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
294000 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
183000 usd
CY2022Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
497000 usd
CY2022Q4 snes Legal Services Current
LegalServicesCurrent
36000 usd
CY2022Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
18000 usd
CY2022Q4 snes Personal Property And Franchise Tax
PersonalPropertyAndFranchiseTax
6000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
560000 usd
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
231000 usd
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
222000 usd
CY2023 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
0 usd
CY2022 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
35000 usd
CY2023 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
0 usd
CY2022 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1000 usd
CY2023 snes Finance Lease Cost
FinanceLeaseCost
0 usd
CY2022 snes Finance Lease Cost
FinanceLeaseCost
36000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
225000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
225000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
8000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
217000 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4533 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2071.2
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y10M24D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
20163 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
69.48
CY2022 snes Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm
P5Y
CY2022 snes Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue
0 usd
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1278 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
CY2022 snes Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodIntrinsicValue
0 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
16 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0
CY2022 snes Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriodIntrinsicValue
0 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
23402 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
204.00
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y10M24D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
16616 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
15.00
CY2023 snes Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm
P5Y
CY2023 snes Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue
0 usd
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
3282 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
CY2023 snes Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodIntrinsicValue
0 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
28 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0
CY2023 snes Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriodIntrinsicValue
0 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
36708 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
119.70
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
20634 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
154.31
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y9M18D
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
CY2023Q4 us-gaap Share Price
SharePrice
15.00
CY2022Q4 us-gaap Share Price
SharePrice
71.52
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
555000 usd
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
711000 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.038
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.037
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.235
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.143
CY2023 snes Effective Income Tax Rate Reconciliation Return To Provision And Other Percent
EffectiveIncomeTaxRateReconciliationReturnToProvisionAndOtherPercent
-0.001
CY2022 snes Effective Income Tax Rate Reconciliation Return To Provision And Other Percent
EffectiveIncomeTaxRateReconciliationReturnToProvisionAndOtherPercent
-0.079
CY2023 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.012
CY2022 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.025
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
22167000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
20498000 usd
CY2023Q4 snes Deferred Tax Assets Capitalized Research And Development Costs
DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts
608000 usd
CY2022Q4 snes Deferred Tax Assets Capitalized Research And Development Costs
DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts
432000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
260000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
253000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Other
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther
59000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Other
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther
92000 usd
CY2023Q4 snes Deferred Tax Assets Leasing Arrangements
DeferredTaxAssetsLeasingArrangements
54000 usd
CY2022Q4 snes Deferred Tax Assets Leasing Arrangements
DeferredTaxAssetsLeasingArrangements
89000 usd
CY2023Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
4000 usd
CY2022Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
11000 usd
CY2023Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
11000 usd
CY2022Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
8000 usd
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
2000 usd
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1000 usd
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
23165000 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
21384000 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
23113000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
21298000 usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
52000 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
86000 usd
CY2023Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
52000 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
86000 usd
CY2023Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
52000 usd
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
86000 usd
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
91200000 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
78000000 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
46800000 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
91200000 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 usd
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
5631 shares
CY2023Q2 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
71429 shares
CY2023Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
21.00
CY2023Q4 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
450306 shares
CY2023Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
1.30
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
18926 shares
CY2022 snes Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
360441 shares
CY2022 snes Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
10916 shares
CY2022 snes Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
507 shares
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
367944 shares
CY2023 snes Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
11954733 shares
CY2023 snes Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
4544437 shares
CY2023 snes Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
2506 shares
CY2023Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
7775734 shares
CY2023Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
7775734 shares
CY2023Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2.95
CY2023Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2.95
CY2023Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
7775734 shares
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6755010 shares
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
184092 shares
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001628280-24-005919-index-headers.html Edgar Link pending
0001628280-24-005919-index.html Edgar Link pending
0001628280-24-005919.txt Edgar Link pending
0001628280-24-005919-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
snes-20231231.htm Edgar Link pending
snes-20231231.xsd Edgar Link pending
snes-20231231xex211.htm Edgar Link pending
snes-20231231xex231.htm Edgar Link pending
snes-20231231xex311.htm Edgar Link pending
snes-20231231xex312.htm Edgar Link pending
snes-20231231xex321.htm Edgar Link pending
snes-20231231_g1.jpg Edgar Link pending
snes-20231231_g2.jpg Edgar Link pending
snes-20231231_def.xml Edgar Link unprocessable
snes-20231231_g3.jpg Edgar Link pending
snes-20231231_pre.xml Edgar Link unprocessable
snes-20231231_htm.xml Edgar Link completed
snes-20231231_lab.xml Edgar Link unprocessable
snes-20231231_cal.xml Edgar Link unprocessable